NCT03287856View on ClinicalTrials.gov

NVT ALLEGRA TAVI System TF in Failing Surgical Aortic Bioprosthesis

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 11, 2017

Primary Completion Date

September 27, 2018

Study Completion Date

October 27, 2019

Conditions
Transcatheter Aortic Valve Implantation
Interventions
DEVICE

Transcatheter Aortic Valve Implantation (TAVI)

Implantation of the ALLEGRA Transcatheter Heart Valve in failing surgical bioprosthesis

Trial Locations (5)

Unknown

Segeberger Kliniken, Herzzentrum, Bad Segeberg

Immanuel Klinik Bernau Herzzentrum Brandenburg, Bernau bei Berlin

Mitteldeutsches Herzzentrum Universitätsklinikum Halle (Saale), Halle

Asklepios Klinik St. Georg, Hamburg

Universitäres Herzzentrum Hamburg GmbH, Hamburg

All Listed Sponsors
lead

NVT GmbH

INDUSTRY

NCT03287856 - NVT ALLEGRA TAVI System TF in Failing Surgical Aortic Bioprosthesis | Biotech Hunter | Biotech Hunter